S100A4 and chronic obstructive pulmonary disease: Furthermore, the S100A4-positive basal cells were markedly enhanced in both COPD-ES and CS groups as compared to the HC (P <0.01 and <0.05, respectively) and asthma (P <0.01 and <0.5, respectively).